Topcis are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gills | 3 | 2013 | 4 | 0.980 |
Why?
|
| Transcriptome | 3 | 2021 | 201 | 0.900 |
Why?
|
| Bass | 2 | 2013 | 2 | 0.890 |
Why?
|
| Metals, Heavy | 2 | 2013 | 2 | 0.890 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 67 | 0.790 |
Why?
|
| Communicable Diseases | 1 | 2020 | 7 | 0.780 |
Why?
|
| Xenopus | 3 | 2019 | 5 | 0.710 |
Why?
|
| Blastomeres | 1 | 2015 | 3 | 0.540 |
Why?
|
| Water Pollutants, Chemical | 2 | 2012 | 6 | 0.520 |
Why?
|
| Animals | 12 | 2023 | 1545 | 0.490 |
Why?
|
| Soil Pollutants | 1 | 2013 | 2 | 0.470 |
Why?
|
| Neutrophils | 3 | 2023 | 33 | 0.450 |
Why?
|
| Humans | 11 | 2023 | 4119 | 0.440 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 14 | 0.440 |
Why?
|
| Geologic Sediments | 1 | 2011 | 3 | 0.410 |
Why?
|
| Biomarkers | 4 | 2020 | 188 | 0.320 |
Why?
|
| Lung | 2 | 2023 | 35 | 0.270 |
Why?
|
| Lung Diseases | 2 | 2022 | 14 | 0.270 |
Why?
|
| Pandemics | 2 | 2021 | 25 | 0.250 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 6 | 0.230 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 5 | 0.220 |
Why?
|
| Hydrocephalus | 1 | 2022 | 6 | 0.210 |
Why?
|
| Interferon-alpha | 1 | 2021 | 8 | 0.210 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 24 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 40 | 0.200 |
Why?
|
| Confidentiality | 1 | 2021 | 8 | 0.200 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 12 | 0.200 |
Why?
|
| Datasets as Topic | 1 | 2021 | 16 | 0.200 |
Why?
|
| Precision Medicine | 1 | 2021 | 22 | 0.200 |
Why?
|
| Machine Learning | 1 | 2021 | 27 | 0.200 |
Why?
|
| Workflow | 1 | 2020 | 21 | 0.190 |
Why?
|
| Perciformes | 2 | 2011 | 2 | 0.190 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 10 | 0.190 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 11 | 0.190 |
Why?
|
| Myelopoiesis | 1 | 2020 | 13 | 0.190 |
Why?
|
| Myeloid Cells | 1 | 2020 | 31 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 345 | 0.180 |
Why?
|
| Male | 3 | 2021 | 1811 | 0.170 |
Why?
|
| Italy | 3 | 2013 | 32 | 0.170 |
Why?
|
| Xenopus Proteins | 2 | 2015 | 3 | 0.170 |
Why?
|
| Female | 3 | 2021 | 2147 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 95 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 133 | 0.150 |
Why?
|
| Apoptosis | 2 | 2013 | 94 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2015 | 3 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 210 | 0.130 |
Why?
|
| Models, Animal | 1 | 2015 | 15 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 32 | 0.130 |
Why?
|
| Body Patterning | 1 | 2015 | 14 | 0.130 |
Why?
|
| Metallothionein | 2 | 2011 | 2 | 0.130 |
Why?
|
| Blastula | 1 | 2014 | 1 | 0.120 |
Why?
|
| Gadus morhua | 1 | 2013 | 1 | 0.120 |
Why?
|
| Light | 1 | 2013 | 14 | 0.120 |
Why?
|
| Environmental Monitoring | 2 | 2012 | 5 | 0.120 |
Why?
|
| Anaerobiosis | 1 | 2013 | 3 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2013 | 4 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2013 | 30 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2015 | 263 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2013 | 38 | 0.120 |
Why?
|
| Anthozoa | 1 | 2013 | 4 | 0.120 |
Why?
|
| Biodiversity | 1 | 2013 | 27 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2013 | 129 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 39 | 0.110 |
Why?
|
| Mytilus | 1 | 2012 | 1 | 0.110 |
Why?
|
| Bacteria | 1 | 2013 | 86 | 0.110 |
Why?
|
| Metabolomics | 1 | 2012 | 24 | 0.110 |
Why?
|
| Mutation | 1 | 2015 | 608 | 0.110 |
Why?
|
| Aquaporin 3 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 1 | 0.100 |
Why?
|
| Toxicity Tests, Subchronic | 1 | 2011 | 1 | 0.100 |
Why?
|
| Biological Availability | 1 | 2011 | 3 | 0.100 |
Why?
|
| Random Allocation | 1 | 2011 | 4 | 0.100 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2011 | 4 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2011 | 18 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 97 | 0.100 |
Why?
|
| Cadmium | 1 | 2011 | 2 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 64 | 0.100 |
Why?
|
| Proteomics | 2 | 2022 | 77 | 0.100 |
Why?
|
| Inflammation | 2 | 2023 | 179 | 0.100 |
Why?
|
| Mice | 2 | 2023 | 737 | 0.100 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 5 | 0.090 |
Why?
|
| Thorax | 1 | 2022 | 2 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2022 | 10 | 0.050 |
Why?
|
| Tripartite Motif Proteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Biomechanical Phenomena | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2022 | 6 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Monocytes | 1 | 2022 | 57 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 31 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 2021 | 5 | 0.050 |
Why?
|
| United States | 1 | 2021 | 10 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 13 | 0.050 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2012 | 3 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 13 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Leukocytes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Brain | 1 | 2022 | 153 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2021 | 5 | 0.050 |
Why?
|
| Leukemia | 1 | 2021 | 37 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2021 | 15 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 22 | 0.050 |
Why?
|
| Macrophages | 1 | 2022 | 124 | 0.050 |
Why?
|
| Base Sequence | 1 | 2021 | 275 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2021 | 55 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2021 | 62 | 0.050 |
Why?
|
| RNA | 1 | 2021 | 54 | 0.050 |
Why?
|
| CD11 Antigens | 1 | 2020 | 5 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2020 | 8 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2021 | 99 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 90 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 322 | 0.050 |
Why?
|
| Proteome | 1 | 2020 | 57 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2020 | 261 | 0.050 |
Why?
|
| Software | 1 | 2021 | 133 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2019 | 4 | 0.040 |
Why?
|
| Gene Library | 1 | 2019 | 20 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 479 | 0.040 |
Why?
|
| Aged | 1 | 2020 | 580 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 843 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 944 | 0.040 |
Why?
|
| RNA, Messenger, Stored | 1 | 2014 | 1 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2014 | 6 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2014 | 12 | 0.030 |
Why?
|
| Poly A | 1 | 2014 | 7 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 21 | 0.030 |
Why?
|
| Zebrafish | 1 | 2014 | 57 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 92 | 0.030 |
Why?
|
| Adaptation, Ocular | 1 | 2013 | 1 | 0.030 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 1 | 0.030 |
Why?
|
| Catalase | 1 | 2013 | 6 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 36 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 9 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 13 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2013 | 50 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 13 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 40 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 301 | 0.030 |
Why?
|
| Sicily | 1 | 2012 | 1 | 0.030 |
Why?
|
| Phylogeny | 1 | 2013 | 208 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 256 | 0.030 |
Why?
|
| Calmodulin | 1 | 2011 | 2 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 2 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 8 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 14 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 43 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Mediterranean Sea | 1 | 2010 | 2 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 5 | 0.020 |
Why?
|
| Bile | 1 | 2010 | 3 | 0.020 |
Why?
|
| Comet Assay | 1 | 2010 | 3 | 0.020 |
Why?
|
| Micronucleus Tests | 1 | 2010 | 6 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 61 | 0.020 |
Why?
|
